Clinical Trial

Cryoneurolysis of the Suprascapular Nerve for Perioperative Pain Control After Receiving a Reverse Total Shoulder Arthroplasty (RTSA)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 15, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The main purpose of this research is to find out if a treatment called cryoneurolysis can reduce pain after reverse total shoulder replacement surgery. This treatment uses cold to temporarily block a nerve in the shoulder. The study will compare people who receive the treatment to those who do not, to see if it helps lower pain and reduce the need for opioid pain medications after a reverse total shoulder surgery (RTSA).
Trial Details
NCT Number NCT07125833
Lead Sponsor North Texas Medical Research Institute, PLLC
Collaborators: Pacira Pharmaceuticals, Inc
Conditions Degenerative Joint Disease of Shoulder
Enrollment 20 participants
Start Date 2025-07-30
Primary Completion 2026-07 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-08-15